In-vitro diagnostic medical device companies, whose stock prices soared amid expectations for growth during the COVID-19 pandemic, are struggling to escape from a recent slump.Top diagnostic companies, including Seegene, SD Biosensor, and Humasis, have also seen their share prices drop sharply.Seege
Plasmapp, a bio plasma technology company, said it would expand its research and development (R&D) platform to accelerate the development of its pipeline biomedical devices by going public on the Kosdaq market this month.The company was founded at the lab of the Korea Advanced Institute of Science a
Korea is utilizing only a fraction of the potential of next generation sequencing (NGS) and has yet to recognize the full value of the platform, Illumina's sales head for the Asia region said."Korea should make efforts to let the public know the cost-effectiveness of NGS in reducing medical costs,"
Panagene, a domestic molecular diagnostics company, said on Tuesday that it obtainedapproval from the Ministry of Food and Drug Administration (MFDS) for its PNA Clamp TERT Mutation Detection Kit.The telomerase reverse transcriptase (TERT) gene is a key factor in elongating telomeres, a repeatable s
“Patient-centeredness" is essential to develop digital healthcare, an expert pointed out Thursday. Moving away from the existing evaluation of commercial viability, it is necessary to look at it differently with an assessment focusing on the value that can be given to patients, the expert added.Lee
NGeneBio said on Friday it has developed a prototype of a blood-based in vitro diagnostic device to detect early dementia using a biomarker discovered in the National Dementia Research and Development project.The importance of early diagnosis of dementia is growing in Korea with the rapid population
Vuno, a company specialising in global medical artificial intelligence (AI) solutions, said on Thursday that its AI-based fundus reading solution VUNO Med-Fundus AI has obtained medical device certification from Singapore’s Health Sciences Authority (HSA).Singapore is attracting attention as a bridg
All automatic dyeing devices for biopsy introduced by Abbott Korea have become the targets of recall by the Ministry of Food and Drug Safety, it was learned.According to the ministry, the regulator has recently put Abbott Korea’s automatic dyeing device, Alinity h-series, on its list subject to reca
Deep Bio said it signed a partnership with Visiopharm, a Danish pharmaceutical company, to supply DeepDx Prostate, its deep learning-based prostate cancer pathology image analysis software.Under the agreement, Deep Bio will be able to expand pathologists' access to advanced AI pathology solutions by
MiCo BioMed, an in-vitro diagnostic medical device maker, said it obtained the Ministry of Food and Drug Safety’s export approval for its monkeypox test kit on Wednesday.MiCo BioMed developed the test kit, called “'Veri-Q MCMPx-VS,” through the Korea Disease Control and Prevention Agency’s 2016 rese
Metaverse, often criticized for lacking in substance, is winning recognition for its value as a new educational platform in the medical field. Experts say it has a high potential for educating not just medical students but hospital staff and patients as well.The experts made these and other points a
The Asian Oceanian Congress of Radiology and Korean Congress of Radiology 2022 (AOCR 2022 & KCR 2022) kicked off its five-day run in COEX, southern Seoul, on Tuesday.KCR is one of the leading radiology conferences in Asia hosted by the Korean Society of Radiology (KSR). This year is also the first t
Panagene said on Monday it signed a contract with Yuhan Corp. to jointly develop the original companion diagnostic (CDx), called PANAMutyper R EGFR, for Yuhan’s lung cancer drug Leclaza (lazertinib).According to the FDA, a CDx is a medical device which provides information that is essential for the
Genomictree said that it has started selling Earlytect, its colorectal cancer screening service, through Malaysia's largest telemedicine platform, DoctorOnCall.Genomictree plans to expand the market share by diversifying sales channels, establishing a telemedicine business model through DoctorOnCall
“Sometimes, we find it difficult to explain some parts even with pictures from anatomy textbooks. For example, in which direction the blood flows in the heart or how the aorta goes up and down. However, by using virtual reality (VR) contents, we can confirm these things more easily, and the body vie
Wells Bio said Monday that "careGENE HPV detection kit-M," an independently developed human papillomavirus (HPV) molecular diagnosis kit, has obtained domestic permission.The in vitro diagnostic device helps diagnose HPV infection by detecting DNA extracted from women's cervical liquid cell samples
GE Healthcare Korea said UGAP (Ultrasound-Guided Attenuation Parameter), which can quantitatively scan for hepatic steatosis of non-alcoholic fatty liver disease (NAFLD) using B-mode ultrasound attenuation coefficient, was recognized by the government as newmedical technology.UGAP makes quantitative
Korean physicians expressed their high expectations for SpaceOAR, Boston Scientific's new medical device that reduces side effects in radiation therapy for prostate cancer patients.SpaceOAR device reduces the amount of radiation delivered to the rectum by injecting a hydrogel barrier between the pro
As the government moves toward allowing the publication of non-paid medical expense information by one-line platforms, such as “Gangnam Sister," plastic surgeons opposed the move, saying it would allow patient solicitation and lower medical quality.On Sept. 5, the government held an online meeting o
The domestic biopharmaceutical businesses’ interests in digital treatment technology were “hot” if a recent industrial fair was any guide.More than 100 industry officials from biopharmaceutical companies, medical institutions, and the digital healthcare sector participated in the “Digital Healthcare